GRAIL INC (GRAL) — insider trading
Health Care · NASDAQ
GRAIL INC (GRAL) has 12 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 12 (latest 2026-07-15).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | MIZELL STEVEN | Director | Grant / award / vesting | 268 | $74.36 | $19.9K | Form 4 |
| 2026-07-15 | SUMME GREGORY L | Director | Grant / award / vesting | 427 | $74.36 | $31.8K | Form 4 |
| 2026-07-15 | CHASE WILLIAM J | Director | Grant / award / vesting | 276 | $74.36 | $20.5K | Form 4 |
| 2026-06-18 | Krevans Sarah | Director | Grant / award / vesting | 5,491 | $63.74 | $350.0K | Form 4 |
| 2026-06-18 | SUMME GREGORY L | Director | Grant / award / vesting | 5,491 | $63.74 | $350.0K | Form 4 |
| 2026-06-18 | MIZELL STEVEN | Director | Grant / award / vesting | 5,491 | $63.74 | $350.0K | Form 4 |
| 2026-06-18 | CHASE WILLIAM J | Director | Grant / award / vesting | 5,491 | $63.74 | $350.0K | Form 4 |
| 2026-06-04 | Partridge Andrew John | Officer (Chief Growth Officer) | Open-market sale | 1,491 | $61.08 | $91.1K | Form 4 |
| 2026-06-03 | Ofman Joshua J. | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 3,154 | $61.13 | $192.8K | Form 4 |
| 2026-06-01 | Ofman Joshua J. | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 27,901 | $64.40 | $1.80M | Form 4 |
| 2026-04-15 | CHASE WILLIAM J | Director | Grant / award / vesting | 408 | $49.79 | $20.3K | Form 4 |
| 2026-04-15 | MIZELL STEVEN | Director | Grant / award / vesting | 396 | $49.79 | $19.7K | Form 4 |
Ask the chat about GRAL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: GRAIL INC (GRAL).
Last updated 2026-07-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.